DOTT.C.CAGNOLA

ALSIDIABE 30 CAPSULES 15.3G

ALSIDIABE 30 CAPSULES 15.3G

Skip to product information
1 of 1
  • Secure payment
  • Discreet and sanitized package
  • Fast and safe shipping

Description

Descriptive sheet

Alsidiabetes

Chromium and vitamin B3 dietary supplement, with cinnamon. Also useful as a preventative measure, in individuals predisposed by their constitution or poor diet, to high blood glucose levels and the resulting onset of diabetes.
Treatment with this product reduces not only serum glucose but also triglycerides, LDL cholesterol and total cholesterol.

Ingredients for 1 capsule
Chromium 60 µg; vitamin B3 20 mg; cinnamon dry extract 344.8 mg (catechins supplied 18 mg).

How to use
1 capsule per day.

Format
Pack of 30 capsules (100% plant-based capsules).

DOTT.C.CAGNOLA

ALSIDIABE 30 CAPSULES 15.3G

ALSIDIABE 30 CAPSULES 15.3G

MINSAN code: 912461199
EAN Code: 4000307118411
Previous price: €17,73
Regular price €17,73
Regular price €19,50 Sale price €17,73
-9% Sold out
Tax included. Shipping calculated at checkout.
View full details

Product images are purely indicative and may not be fully representative of the packaging and product features, as they may vary in color, size, or content. Any decorations, gift wrapping, and items included in the images for product presentation purposes will not be shipped with orders. Product names, ingredients, and percentages indicated in the descriptions are purely indicative and may be subject to change or updates by the manufacturers. Due to the impossibility of updating these updates in real time, the photos and technical information of the products listed on farmaInnovation.it may differ from those shown on the label or otherwise disclosed by the manufacturers. The only identifying element is the MINSAN (Ministry of Health) code. Farmacia Barni, farmainnovation.it , does not guarantee the accuracy and timeliness of the information published and declines all responsibility for any errors, omissions, or failure to update it. farmainnovation.it assumes no responsibility for damages of any kind that may arise from accessing the published information.